The Academy of Managed Care Pharmacy (AMCP) is writing in strong support of H.R. 3545 – the “Overdose Prevention and Patient Safety Act”. As you know, H.R. 3545 has bipartisan support and was introduced by Reps. Markwayne Mullin (R-OK), Earl Blumenauer (R-OR), Jim Renacci (R-OH), Buddy Carter (R-GA) and Pat Meehan (R-PA).
AMCP CEO Blog: Usually I delete emails like the one I received recently, but this one got me thinking. It was addressed to one of my predecessors, and invited her to publish a paper in a journal on patient care and nursing.
On April 2, 2018 CMS released the Final CY 2019 Call Letter for Medicare Advantage (MA) and Medicare Part D Plans. There were no substantial changes to the proposals included in the Draft Call Letter, which were finalized generally as proposed. The agency did update the Standard Benefit Parameters to reflect the changes to the coverage gap that were included in the Bipartisan Budget Act of 2018.